Anti-N. meningitidis subtype 9 Recombinant Antibody (5F81A4P1.9) (MRO-153MZ) (CAT#: MRO-153MZ)

This monoclonal antibody which is specific for subtype 9 antigen of Neisseria meningitidis can be potentially used for treating N. meningitidis infections.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 The immunoglobulin class and subclass of the MAb of cell line 5F81A4 was characterized by ELISA as being IgG (Ig2a, kappa light chain).

Figure 1 The immunoglobulin class and subclass of the MAb of cell line 5F81A4 was characterized by ELISA as being IgG (Ig2a, kappa light chain).

This MAb was assessed with a Dot-Blot assay for specificity to reference strain P1.9 (M982) (Figure.1:2g) and to case strains N368/88, N398/92, N16/92, N17/92, N23/92, N35/92, N402/92, N403/92, and P1.9 (Figure.1:1a,b), using culture supernatant and ascites fluid, respectively.

Production of monoclonal antibody to subtype 9 of Neisseria meningitidis and the distribution of this subtype in Brazil

WB

Figure 2 The immunoglobulin class and subclass of the MAb of cell line 5F81A4 was characterized by ELISA as being IgG (Ig2a, kappa light chain).

Figure 2 The immunoglobulin class and subclass of the MAb of cell line 5F81A4 was characterized by ELISA as being IgG (Ig2a, kappa light chain).

This MAb bound by immunoblot (Figure.1:4) to the class 1 protein, when 0.25% of Empigen BB detergent was added to restore the antibody binding activity to this class 1 subtype N368/88 protein (Figure.1:4a), N16/92 (4c), N 23/92 (4e).

Production of monoclonal antibody to subtype 9 of Neisseria meningitidis and the distribution of this subtype in Brazil

FC

Figure 3 The ability of the 5F81A4 MAb to bind to 46 kDa protein on the surface ofthe pathogenic N. meningitidis group B strain was also determined by indirect immunofluorescence assay and was analyzed by flow cytometry.

Figure 3 The ability of the 5F81A4 MAb to bind to 46 kDa protein on the surface ofthe pathogenic N. meningitidis group B strain was also determined by indirect immunofluorescence assay and was analyzed by flow cytometry.

The B:4:P1.9 strain of N. meningitidis was used.

Production of monoclonal antibody to subtype 9 of Neisseria meningitidis and the distribution of this subtype in Brazil


Specifications

  • Immunogen
  • A saline suspension of N. meningitidis 368/88
  • Host Species
  • Mouse
  • Specificity
  • Neisseria meningitidis
  • Clone
  • 5F81A4P1.9
  • Applications
  • ELISA, WB, FC
  • Related Disease
  • N. meningitidis infection

Applications

  • Application Notes
  • The N. meningitidis Subtype 9 antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Western Blot, Flow Cytometry.

Target

  • Alternative Names
  • N. meningitidis subtype 9

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 5F81A4P1.9"

See other products for "N. meningitidis subtype 9"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-153MZ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare